PEDIATRIC CELL THERAPY & GROWTH-SAFE RADIOTHERAPY
Advanced Childhood Cancer Care in China
Childhood cancers—including pediatric leukemia, neuroblastoma, and brain tumors—demand treatments that achieve complete cure while strictly protecting a growing child’s organs, intellect, and physical development. China operates the world’s highest-volume pediatric CAR-T and bone marrow transplant centers, alongside child-friendly proton radiation that protects growing tissues.
- Relapsed or Refractory Pediatric Leukemia (ALL & AML)
- High-Risk Neuroblastoma, Wilms Tumor, and Medulloblastoma
- Children Requiring Radiation Who Need Protection for Brain & Growth
- Dedicated Pediatric Hematology-Oncology Units with Sterile Suites
- Over 90% Complete Remission Rates with Pediatric CAR-T Cells
- Family-Centered Care with Dedicated English Bedside Navigators
ADVANCED TREATMENT OPTIONS
Key Childhood Cancer Treatments
Pediatric CAR-T Cell Therapy
Child-Safe Proton Particle Therapy
Half-Match Pediatric Transplant
WHY CHOOSE US
Why Choose China for Childhood Cancer
China’s national pediatric medical centers treat the world’s largest cohorts of childhood hematologic and solid tumors. Pediatric CAR-T cellular therapy programs in Beijing and Shanghai have treated thousands of children from around the world, achieving unmatched complete remission rates in relapsed acute lymphoblastic leukemia.
For pediatric brain and spinal tumors, national proton centers offer child-tailored particle therapy that virtually eliminates long-term cognitive and hormonal deficits. Hospitals provide welcoming, family-centered private rooms where parents can stay with their child, supported by bilingual clinical coordinators and transparent public billing.
HOW IT WORKS
4 Steps to Treatment in China
01. Submit Records Online
02. Pre-Screen & Doctor Match
03. Doctor Consultation
04. Travel to China & Care
PATIENT FAQS
Frequently Asked Questions
CONFIDENTIAL CASE EVALUATION
Start with a Confidential Clinical Case Review
Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.
✓ Free initial triage • ✓ Direct specialist coordination • ✓ 100% Confidential